Association of dietary total antioxidant capacity with all-cause and cardiovascular mortality in patients with chronic kidney disease: based on two retrospective cohort studies of NHANES

References

• Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):1–11.
   PubMed Web of Science ®Google Scholar
• MacLaughlin HL, Friedman AN, Ikizler TA. Nutrition in kidney disease: core curriculum 2022. Am J Kidney Dis. 2022;79(3):437–449.
   PubMed Web of Science ®Google Scholar
• Duni A, Liakopoulos V, Roumeliotis S, et al. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling ariadne’s thread. Int J Mol Sci. 2019;20(15):3711.
   PubMed Web of Science ®Google Scholar
• Okamura DM, Pennathur S. The balance of powers: redox regulation of fibrogenic pathways in kidney injury. Redox Biol. 2015;6:495–504.
   PubMed Web of Science ®Google Scholar
• Nezu M, Suzuki N, Yamamoto M. Targeting the KEAP1-NRF2 system to prevent kidney disease progression. Am J Nephrol. 2017;45(6):473–483.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Chertow GM, Devarajan P, et al. Chronic inflammation in chronic kidney disease progression: role of Nrf2. Kidney Int Rep. 2021;6(7):1775–1787.
   PubMed Web of Science ®Google Scholar
• Lu Y, Sun Y, Liu Z, et al. Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease. Sci Transl Med. 2020;12(554):eaba3613.
   Web of Science ®Google Scholar
• Schwarz M, Lossow K, Kopp JF, et al. Crosstalk of Nrf2 with the trace elements selenium, iron, zinc, and copper. Nutrients. 2019;11(9):2112.
   PubMed Web of Science ®Google Scholar
• Huang Z, Jing X, Sheng Y, et al. (-)-epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury. Redox Biol. 2019;22:101117.
   PubMed Web of Science ®Google Scholar
• Mohan T, Narasimhan KKS, Ravi DB, et al. Role of Nrf2 dysfunction in the pathogenesis of diabetic nephropathy: therapeutic prospect of epigallocatechin-3-gallate. Free Radic Biol Med. 2020;160:227–238.
   PubMed Web of Science ®Google Scholar
• Mafra D, Borges NA, Lindholm B, et al. Food as medicine: targeting the uraemic phenotype in chronic kidney disease. Nat Rev Nephrol. 2021;17(3):153–171.
   PubMed Web of Science ®Google Scholar
• Nascimento-Souza MA, Paiva PG, Martino HSD, et al. Dietary total antioxidant capacity as a tool in health outcomes in middle-aged and older adults: a systematic review. Crit Rev Food Sci Nutr. 2018;58(6):905–912.
   PubMed Web of Science ®Google Scholar
• Wright ME, Mayne ST, Stolzenberg-Solomon RZ, et al. Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol. 2004;160(1):68–76.
   PubMed Web of Science ®Google Scholar
• Floegel A, Kim DO, Chung SJ, et al. Development and validation of an algorithm to establish a total antioxidant capacity database of the US diet. Int J Food Sci Nutr. 2010;61(6):600–623.
   PubMed Web of Science ®Google Scholar
• Kim DO, Lee CY. Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit Rev Food Sci Nutr. 2004;44(4):253–273.
   PubMed Web of Science ®Google Scholar
• Lee J, Oh KH, Park SK. Dietary micronutrients and risk of chronic kidney disease: a cohort study with 12 year Follow-Up. Nutrients. 2021;13(5):1517.
   PubMed Web of Science ®Google Scholar
• Farhadnejad H, Asghari G, Mirmiran P, et al. Micronutrient intakes and incidence of chronic kidney disease in adults: Tehran lipid and glucose study. Nutrients. 2016;8(4):217.
   PubMed Web of Science ®Google Scholar
• Hu EA, Coresh J, Anderson CAM, et al. Adherence to healthy dietary patterns and risk of CKD progression and all-cause mortality: findings from the CRIC (chronic renal insufficiency cohort) study. Am J Kidney Dis. 2021;77(2):235–244.
   PubMed Web of Science ®Google Scholar
• Ahluwalia N, Dwyer J, Terry A, et al. Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr. 2016;7(1):121–134.
   PubMed Web of Science ®Google Scholar
• Ahuja JK, Moshfegh AJ, Holden JM, et al. USDA food and nutrient databases provide the infrastructure for food and nutrition research, policy, and practice. J Nutr. 2013;143(2):241s–249s.
   PubMed Web of Science ®Google Scholar
• Yu YC, Paragomi P, Wang R, et al. Composite dietary antioxidant index and the risk of colorectal cancer: findings from the Singapore Chinese Health Study. Int J Cancer. 2022;150(10):1599–1608.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Cleland CL, Hunter RF, Kee F, et al. Validity of the global physical activity questionnaire (GPAQ) in assessing levels and change in moderate-vigorous physical activity and sedentary behaviour. BMC Public Health. 2014;14:1255.
   PubMed Web of Science ®Google Scholar
• Du Y, Liu B, Sun Y, et al. Trends in adherence to the physical activity guidelines for Americans for aerobic activity and time spent on sedentary behavior among US adults, 2007 to 2016. JAMA Netw Open. 2019;2(7):e197597.
   PubMed Web of Science ®Google Scholar
• Statistics NCfH. Continuous NHANES public-use linked mortality files, 2019. 2022.
   Google Scholar
• Harrell FE. General aspects of fitting regression models. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Cham: Springer; 2015. p. 13–44.
   Google Scholar
• Schneider B. Analysis of clinical trial outcomes: alternative approaches to subgroup analysis. Control Clin Trials. 1989;10(4 Suppl):176S–186S.
   PubMedGoogle Scholar
• Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods. 2010;15(4):309–334.
   PubMed Web of Science ®Google Scholar
• Bach KE, Kelly JT, Palmer SC, et al. Healthy dietary patterns and incidence of CKD: a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2019;14(10):1441–1449.
   PubMed Web of Science ®Google Scholar
• Sahni N, Gupta KL, Rana SV, et al. Intake of antioxidants and their status in chronic kidney disease patients. J Ren Nutr. 2012;22(4):389–399.
   PubMed Web of Science ®Google Scholar
• Alehagen U, Aaseth J, Alexander J, et al. Selenium and coenzyme Q10 supplementation improves renal function in elderly deficient in selenium: observational results and results from a subgroup analysis of a prospective randomised double-blind placebo-controlled trial. Nutrients. 2020;12(12):3780.
   PubMed Web of Science ®Google Scholar
• Xie C, Zeng M, Shi Z, et al. Association between selenium status and chronic kidney disease in middle-aged and older Chinese based on CHNS data. Nutrients. 2022;14(13):2695.
   PubMed Web of Science ®Google Scholar
• Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363–383.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Ikizler TA, Ellis C, et al. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol. 2014;25(3):623–633.
   PubMed Web of Science ®Google Scholar
• Jun M, Venkataraman V, Razavian M, et al. Antioxidants for chronic kidney disease. Cochrane Database Syst Rev. 2012;10(10):Cd008176.
   PubMedGoogle Scholar
• Rapa SF, Iorio D, Campiglia BR, et al. S. Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci. 2019;21(1):263.
   PubMed Web of Science ®Google Scholar
• Sporn MB, Liby KT, Yore MM, et al. New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod. 2011;74(3):537–545.
   PubMed Web of Science ®Google Scholar
• Pergola PE, Raskin P, Toto RD, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med. 2011;365(4):327–336.
   PubMed Web of Science ®Google Scholar
• Nangaku M, Kanda H, Takama H, et al. Randomized clinical trial on the effect of bardoxolone methyl on GFR in diabetic kidney disease patients (TSUBAKI study). Kidney Int Rep. 2020;5(6):879–890.
   PubMed Web of Science ®Google Scholar
• Kanlaya R, Thongboonkerd V. Protective effects of epigallocatechin-3-Gallate from green tea in various kidney diseases. Adv Nutr. 2019;10(1):112–121.
   PubMed Web of Science ®Google Scholar
• Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem. 2019;299:125124.
   PubMed Web of Science ®Google Scholar
• Abbasi M, Daneshpour MS, Hedayati M, et al. Dietary total antioxidant capacity and the risk of chronic kidney disease in patients with type 2 diabetes: a nested case-control study in the Tehran Lipid Glucose Study. J Ren Nutr. 2019;29(5):394–398.
   PubMed Web of Science ®Google Scholar
• Moludi J, Tandorost A, Kamari N, et al. Dietary total antioxidant capacity and its association with renal function and kidney stones: results of a RaNCD cohort study. Food Sci Nutr. 2022;10(5):1442–1450.
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352.
   PubMed Web of Science ®Google Scholar
• Jovanovich A, Isakova T, Stubbs J. Microbiome and cardiovascular disease in CKD. Clin J Am Soc Nephrol. 2018;13(10):1598–1604.
   PubMed Web of Science ®Google Scholar
• de Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med. 2013;369(26):2492–2503.
   PubMed Web of Science ®Google Scholar
• Rossing P, Block GA, Chin MP, et al. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease. Kidney Int. 2019;96(4):1030–1036.
   PubMed Web of Science ®Google Scholar
• Rysz J, Franczyk B, Ławiński J, et al. The impact of CKD on uremic toxins and gut microbiota. Toxins. 2021;13(4):252.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Guo M, Fang X, et al. Gut microbiota-derived trimethylamine N-oxide and kidney function: a systematic review and meta-analysis. Adv Nutr. 2021;12(4):1286–1304.
   PubMed Web of Science ®Google Scholar
• Lano G, Burtey S, Sallée M. Indoxyl sulfate, a uremic endotheliotoxin. Toxins. 2020;12(4):229.
   PubMed Web of Science ®Google Scholar
• Ravid JD, Kamel MH, Chitalia VC. Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease. Nat Rev Nephrol. 2021;17(6):402–416.
   PubMed Web of Science ®Google Scholar
• Ranganathan N, Anteyi E. The role of dietary fiber and gut microbiome modulation in progression of chronic kidney disease. Toxins. 2022;14(3):183.
   PubMed Web of Science ®Google Scholar
• Yang X, Soohoo M, Streja E, et al. Serum magnesium levels and hospitalization and mortality in incident peritoneal dialysis patients: a cohort study. Am J Kidney Dis. 2016;68(4):619–627.
   PubMed Web of Science ®Google Scholar
• Leenders NHJ, Vervloet MG. Magnesium: a magic bullet for cardiovascular disease in chronic kidney disease? Nutrients. 2019;11(2):455.
   PubMed Web of Science ®Google Scholar
• Ferrè S, Li X, Adams-Huet B, et al. Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study. Nephrol Dial Transplant. 2018;33(8):1389–1396.
   PubMed Web of Science ®Google Scholar